| 10729672 |
Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272 |
Laurence Moore, Charles Michael Zacharchuk |
2020-08-04 |
| 10603314 |
Method for treating gefitinib resistant cancer |
Daniel A. Haber, Daphne Winifred Bell, Jeffrey E. Settleman, Raffaella Sordella, Nadia G. Godin-Heymann +1 more |
2020-03-31 |
| 10596162 |
Method for treating gefitinib resistant cancer |
Daniel A. Haber, Daphne Winifred Bell, Jeffrey E. Settleman, Raffaella Sordella, Nadia G. Godin-Heymann +1 more |
2020-03-24 |
| 7982043 |
Protein tyrosine kinase enzyme inhibitors |
Allan Wissner, Hwei-Ru Tsou |
2011-07-19 |
| 7399865 |
Protein tyrosine kinase enzyme inhibitors |
Allan Wissner, Hwei-Ru Tsou |
2008-07-15 |
| RE40418 |
Treatment of neoplasms with CCI-779/EKB-569 combination |
James Gibbons |
2008-07-01 |
| 6878737 |
Reversal of multidrug resistance in human colon carcinoma cells |
Haiyin He, Lee Greenberger |
2005-04-12 |
| 6617333 |
Antineoplastic combinations comprising |
James Gibbons |
2003-09-09 |
| 6372775 |
Reversal of multidrug resistance in human colon carcinoma cells |
Haiyin He, Lee Greenberger |
2002-04-16 |
| 5756343 |
Cell stress transcriptional factors |
Carl Wu, Joachim Clos, J. Timothy Westwood |
1998-05-26 |
